{"id":"W2145161475","doi":"10.1016/s0140-6736(12)60986-6","title":"Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Daiichi-Sankyo; Daiichi Sankyo Company; Regado Biosciences; Medicines Company; CSL Behring; GlaxoSmithKline; Eli Lilly and Company","keywords":"Apixaban; Medicine; Atrial fibrillation; Warfarin; Stroke (engine); Internal medicine; Embolism; Randomized controlled trial; Clinical endpoint; Rivaroxaban; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009961713,0.00009104481,0.001567528,0.0002513658,0.00002201382,0.000003663724,0.00004152802,0.00003036681,0.00002784447],"category_scores_gemma":[0.0003795306,0.00005461763,0.0001694878,0.0003902761,0.00005948444,0.00005052788,0.00004758751,0.0000542323,7.569503e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001092498,"about_ca_system_score_gemma":0.0000192935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009237414,"about_ca_topic_score_gemma":0.0000187001,"domain_scores_codex":[0.9987827,0.0001500631,0.0006534058,0.00009352135,0.0002036077,0.0001167153],"domain_scores_gemma":[0.9980754,0.001059812,0.0005894569,0.0001768617,0.00005818309,0.00004027312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4985457,0.000006264945,0.4947183,0.00005174768,0.001527946,8.323761e-8,0.001295952,0.001706884,0.0006276615,0.00004892749,0.000007044196,0.001463556],"study_design_scores_gemma":[0.5873989,0.000437999,0.4060739,0.0000718232,0.003032209,2.960143e-7,0.0006069728,0.001921576,0.0003317297,0.000004192867,0.00006704827,0.00005332622],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967677,0.0003106184,0.0001127745,0.0001695658,0.00005188119,0.002105651,0.00003787349,0.000004698082,0.0004392295],"genre_scores_gemma":[0.9991299,0.00006705042,0.0004262997,0.000007066574,0.0003348362,0.000001971194,0.000009259894,0.000005153614,0.00001846562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08885324,"threshold_uncertainty_score":0.2227242,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0400351424776182,"score_gpt":0.3079300448470321,"score_spread":0.2678949023694139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}